<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ETF Trends &#187; Pharmaceuticals</title>
	<atom:link href="http://www.etftrends.com/tag/pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.etftrends.com</link>
	<description>Setting the Pace for Exchange Traded Funds</description>
	<lastBuildDate>Sat, 26 May 2012 10:00:50 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pharmaceutical ETFs: A Defensive Play in 2012?</title>
		<link>http://www.etftrends.com/2012/04/pharmaceutical-etfs-a-defensive-play-in-2012/</link>
		<comments>http://www.etftrends.com/2012/04/pharmaceutical-etfs-a-defensive-play-in-2012/#comments</comments>
		<pubDate>Wed, 25 Apr 2012 11:00:27 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=83337</guid>
		<description><![CDATA[There are several obstacles that are facing the health care industry this year, as well as the pharmaceutical sub-sector. For those investors that are attracted to this defensive investment, there are exchange traded funds that offer a compelling choice.
&#8220;After strength earlier in the year, pharmaceutical stocks weakened in recent weeks, with the Pharmaceuticals sub-industry essentially [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2012/04/pharmaceutical-etfs-a-defensive-play-in-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Six HOLDRS Become Van Eck ETFs</title>
		<link>http://www.etftrends.com/2011/12/six-holdrs-become-van-eck-etfs/</link>
		<comments>http://www.etftrends.com/2011/12/six-holdrs-become-van-eck-etfs/#comments</comments>
		<pubDate>Wed, 21 Dec 2011 12:16:48 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[New ETFs]]></category>
		<category><![CDATA[Banks]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[OIH]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>
		<category><![CDATA[Retail]]></category>
		<category><![CDATA[RKH]]></category>
		<category><![CDATA[RTH]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Semiconductors]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[SMH]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=72136</guid>
		<description><![CDATA[Six Merrill Lynch HOLDRS exchange traded securities stopped trading as planned on Tuesday. The funds were officially transferred and changed into Van Eck Global exchange traded funds, and the new funds will begin trading Wednesday.
Trading in the biotech, banking, oil services, pharmaceuticals, retail and semiconductor HOLDRs halted on Tuesday, according to Van Eck. [HOLDRS Making [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/12/six-holdrs-become-van-eck-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Utilities, Consumer and Pharma ETFs Lead 2011</title>
		<link>http://www.etftrends.com/2011/12/utilities-consumer-and-pharma-etfs-lead-2011/</link>
		<comments>http://www.etftrends.com/2011/12/utilities-consumer-and-pharma-etfs-lead-2011/#comments</comments>
		<pubDate>Mon, 19 Dec 2011 12:31:29 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Consumer Staples]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[VDC]]></category>
		<category><![CDATA[XLP]]></category>
		<category><![CDATA[XLU]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=71788</guid>
		<description><![CDATA[Disruptions in the global economy have kept international equities suppressed, with a devastating Japanese earthquake crippling the normal supply chain between the Asia economies and escalating concerns over the Eurozone financial debt crisis. However, investors who opted to stick it out in domestic equity markets and exchange traded funds fared much better.
According to an S&#38;P [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/12/utilities-consumer-and-pharma-etfs-lead-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HOLDRS Making Transition to Market Vector ETFs</title>
		<link>http://www.etftrends.com/2011/11/holdrs-making-transition-to-market-vector-etfs/</link>
		<comments>http://www.etftrends.com/2011/11/holdrs-making-transition-to-market-vector-etfs/#comments</comments>
		<pubDate>Wed, 23 Nov 2011 19:44:41 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[New ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[ETF 101]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[OIH]]></category>
		<category><![CDATA[Oil & Gas Exploration]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>
		<category><![CDATA[Retail]]></category>
		<category><![CDATA[RKH]]></category>
		<category><![CDATA[RTH]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Semiconductors]]></category>
		<category><![CDATA[SMH]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=70305</guid>
		<description><![CDATA[Van Eck Global and Bank of America (NYSE: BAC) subsidiary Merrill Lynch reached an accord on six HOLDRs in August, and now, the transition from the Merrill Lynch HOLDRs to Market Vector exchange traded funds is underway.
An exchange offer for the HOLDRS commenced on Nov. 11 and will run till 11:00 am Eastern time on [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/11/holdrs-making-transition-to-market-vector-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sector ETF Performance in 2011</title>
		<link>http://www.etftrends.com/2011/11/sector-etf-performance-in-2011/</link>
		<comments>http://www.etftrends.com/2011/11/sector-etf-performance-in-2011/#comments</comments>
		<pubDate>Sun, 06 Nov 2011 12:00:12 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[XLU]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=68901</guid>
		<description><![CDATA[This year has been tough on stock exchange traded funds, especially those that track foreign markets, but Standard &#38; Poor&#8217;s believes domestic equity-based ETFs could weather the European debt storm.
Of the more than 1,000 exchange traded products available, only 192 ETFs are showing gains for the first 10 months of the year and only nine [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/11/sector-etf-performance-in-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ETF Spotlight: Pharmaceuticals</title>
		<link>http://www.etftrends.com/2011/10/etf-spotlight-pharmaceuticals/</link>
		<comments>http://www.etftrends.com/2011/10/etf-spotlight-pharmaceuticals/#comments</comments>
		<pubDate>Thu, 13 Oct 2011 20:18:47 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[ETF Spotlight]]></category>
		<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[ETF 101]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=66571</guid>
		<description><![CDATA[ETF spotlight on SPDR S&#38;P Pharmaceuticals ETF (NYSEArca: XPH), part of an ongoing series.
Assets: $241.21 million.
Objective: The SPDR S&#38;P Pharmaceuticals ETF tries to reflect the performance of the S&#38;P Pharmaceuticals Select Industry Index, which tracks U.S-listed companies engaged in the pharmaceuticals industry.
Holdings: Top holdings include: Salix Pharma Inc (NasdaqGS: SLXP) 4.57%, Bristol Myers Squibb Co. [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/10/etf-spotlight-pharmaceuticals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Van Eck, Merrill Lynch in Agreement Over HOLDRS</title>
		<link>http://www.etftrends.com/2011/08/van-eck-merrill-lynch-in-agreement-over-holdrs/</link>
		<comments>http://www.etftrends.com/2011/08/van-eck-merrill-lynch-in-agreement-over-holdrs/#comments</comments>
		<pubDate>Mon, 15 Aug 2011 12:26:15 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[New ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Energy]]></category>
		<category><![CDATA[ETF 101]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[OIH]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil & Gas Exploration]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>
		<category><![CDATA[Retail]]></category>
		<category><![CDATA[RKH]]></category>
		<category><![CDATA[RTH]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Semiconductors]]></category>
		<category><![CDATA[SMH]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=60671</guid>
		<description><![CDATA[Van Eck Global and Bank of America (NYSE: BAC) subsidiary Merrill Lynch have reached a deal in which Van Eck plans to offer investors in six HOLDRS the chance to swap for shares of new exchange traded funds.

Van Eck filed for six sector-specific ETFs with the Securities and Exchange Commission to issue the Merrill-Lynch HOLDRs [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/08/van-eck-merrill-lynch-in-agreement-over-holdrs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare ETFs Cling to 2011 Gain</title>
		<link>http://www.etftrends.com/2011/08/healthcare-etfs-cling-to-2011-gain/</link>
		<comments>http://www.etftrends.com/2011/08/healthcare-etfs-cling-to-2011-gain/#comments</comments>
		<pubDate>Mon, 15 Aug 2011 11:54:48 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=59512</guid>
		<description><![CDATA[Healthcare sector exchange traded funds are holding on to slim gains for 2011 but could be volatile the rest of the year after a federal appeals court ruled the individual mandate in the Obama administration&#8217;s healthcare reform plan is unconstitutional.
Health Care Select Sector SPDR Fund (NYSEArca: XLV) is up 1.4% year to date, compared with [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/08/healthcare-etfs-cling-to-2011-gain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech ETFs: Orexigen Hit By Regulatory Hammer</title>
		<link>http://www.etftrends.com/2011/06/biotech-etfs-orexigen-hit-by-regulatory-hammer/</link>
		<comments>http://www.etftrends.com/2011/06/biotech-etfs-orexigen-hit-by-regulatory-hammer/#comments</comments>
		<pubDate>Fri, 03 Jun 2011 19:47:41 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=55162</guid>
		<description><![CDATA[Biotech sector and related exchange traded funds (ETFs) trade lower as one drug maker garners notoriety after regulatory hurdles puts a hold on the advancement of an anticipated diet pill.

iShares Nasdaq Biotechnology (NYSEArca: IBB) is down 0.83%.
First Trust Amex Biotech Index Fund (NYSEAca: FBT) is down 0.74%.
iShares Dow Jones U.S. Pharmaceutical Index Fund (NYSEArca: IHE) [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/06/biotech-etfs-orexigen-hit-by-regulatory-hammer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare, Pharma ETFs Hit by Pfizer Decline</title>
		<link>http://www.etftrends.com/2011/05/healthcare-pharma-etfs-hit-by-pfizer-decline/</link>
		<comments>http://www.etftrends.com/2011/05/healthcare-pharma-etfs-hit-by-pfizer-decline/#comments</comments>
		<pubDate>Tue, 03 May 2011 15:59:08 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=52706</guid>
		<description><![CDATA[A nearly 3% pullback in Pfizer (NYSE: PFE) after the drug giant reported flat quarterly revenue pulled down exchange traded funds (ETFs) that track healthcare and pharmaceuticals stocks on Tuesday.
“Excluding the impact of foreign exchange rates, total sales fell 1% year over year as patent losses weighed on overall growth,” said Morningstar analyst Damien Conover [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/05/healthcare-pharma-etfs-hit-by-pfizer-decline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer to Weigh on Pharma, Healthcare ETFs</title>
		<link>http://www.etftrends.com/2011/05/pfizer-to-weigh-on-pharma-healthcare-etfs/</link>
		<comments>http://www.etftrends.com/2011/05/pfizer-to-weigh-on-pharma-healthcare-etfs/#comments</comments>
		<pubDate>Tue, 03 May 2011 11:54:47 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=52667</guid>
		<description><![CDATA[Healthcare exchange traded funds (ETFs) will face an uphill climb Tuesday following quarterly results from top holding Pfizer (NYSE: PFE), which saw its shares fall over 1% in premarket trading.
Pfizer’s adjusted net income topped expectations and the drug maker reiterated its 2011 outlook. Chief Executive Ian Read said the firm expects to complete an evaluation [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/05/pfizer-to-weigh-on-pharma-healthcare-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Will Pfizer Help or Hurt Rallying Pharma ETFs?</title>
		<link>http://www.etftrends.com/2011/05/will-pfizer-help-or-hurt-rallying-pharma-etfs/</link>
		<comments>http://www.etftrends.com/2011/05/will-pfizer-help-or-hurt-rallying-pharma-etfs/#comments</comments>
		<pubDate>Tue, 03 May 2011 02:05:51 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=52645</guid>
		<description><![CDATA[Exchange traded funds (ETFs) that invest in pharmaceuticals and healthcare stocks have rallied even though shares of top holding Pfizer (NYSE: PFE), which reports quarterly results Tuesday morning, stumbled last month.
Pfizer shares fell in mid-April on worries over four deaths in a study for its arthritis drug tofacitinib. The stock has recovered and on Monday [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/05/will-pfizer-help-or-hurt-rallying-pharma-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer Earnings to Dominate Healthcare, Pharma ETFs</title>
		<link>http://www.etftrends.com/2011/05/pfizer-earnings-to-dominate-healthcare-pharma-etfs/</link>
		<comments>http://www.etftrends.com/2011/05/pfizer-earnings-to-dominate-healthcare-pharma-etfs/#comments</comments>
		<pubDate>Mon, 02 May 2011 23:10:57 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IYH]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=52638</guid>
		<description><![CDATA[Exchange traded funds (ETFs) that invest in healthcare and pharmaceuticals companies will take their cues from sector giant Pfizer (NYSE: PFE) when the company reports first-quarter earnings before Tuesday’s opening bell.
Pfizer is a top holding in Pharmaceutical HOLDRS (AMEX: PPH), Health Care Select Sector SPDR Fund (NYSEArca: XLV) and iShares Dow Jones US Healthcare (NYSEArca: [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/05/pfizer-earnings-to-dominate-healthcare-pharma-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma, Healthcare ETFs in Focus on M&amp;A Talk, Earnings</title>
		<link>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/</link>
		<comments>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 12:29:29 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[IYH]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>
		<category><![CDATA[VHT]]></category>
		<category><![CDATA[XLV]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=51139</guid>
		<description><![CDATA[Exchange traded funds (ETFs) tracking pharmaceutical and healthcare stocks could see action Monday on news Johnson &#38; Johnson (NYSE: JNJ) is on the prowl for acquisitions and earnings from Eli Lilly (NYSE: LLY).
Swiss device maker Synthes confirmed it is in merger negotiations with J&#38;J, according to reports. Shares of U.K. medical technology company Smith &#38; [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ETFs React to Strong Retail Sales, Egypt Clashes</title>
		<link>http://www.etftrends.com/2011/02/etfs-react-strong-retail-sales-egypt-clashes/</link>
		<comments>http://www.etftrends.com/2011/02/etfs-react-strong-retail-sales-egypt-clashes/#comments</comments>
		<pubDate>Thu, 03 Feb 2011 16:30:39 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Industrial Metals]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PRN]]></category>
		<category><![CDATA[Retail]]></category>
		<category><![CDATA[VAW]]></category>
		<category><![CDATA[XRT]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=45899</guid>
		<description><![CDATA[Despite a dip in jobless claims, strong retail sales, rising factory orders and a spate of positive earnings reports, stocks and exchange traded funds (ETFs) turned negative at the market&#8217;s open.

New U.S. claims for unemployment benefits dropped more than expected last week, a government report showed on Thursday, pointing to continued gradual improvement in the [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/02/etfs-react-strong-retail-sales-egypt-clashes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

